CoChat

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Open access

Published version of a preprint

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

We developed models for individualized risk prediction of cognitive decline in mild cognitive impairment (MCI) using plasma biomarkers of β-amyloid (Aβ), tau and neurodegeneration. A total of 573 patients with MCI from the Swedish BioFINDER study and the Alzheimer's Disease Neuroimaging Initiative (ADNI) were included in the study. The primary outcomes were longitudinal cognition and conversion to Alzheimer's disease (AD) dementia. A model combining tau phosphorylated at threonine 181 (P-tau181) and neurofilament light (NfL), but not Aβ 42 /Aβ 40 , had the best prognosis performance of all models (area under the curve = 0.88 for 4-year conversion to AD in BioFINDER, validated in ADNI), was stronger than a basic model of age, sex, education and baseline cognition, and performed similarly to cerebrospinal fluid biomarkers. A publicly available online tool for individualized prognosis in MCI based on our combined plasma biomarker models is introduced. Combination of plasma biomarkers may be of high value to identify individuals with MCI who will progress to AD dementia in clinical trials and in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1038/s43587-020-00003-5

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 1

  1. Burnham K. P. & Anderson D. R. Model Selection and Multimodel Inference (Springer, 2002).

Cited by

See all 187

Metadata

Authors
Cullen, N. C., Leuzy, A., Palmqvist, S., Janelidze, S., Stomrud, E., Pesini, P., Sarasa, L., Allué, J. A., Proctor, N. K., Zetterberg, H., Dage, J. L., Blennow, K., Mattsson-Carlgren, N., & Hansson, O.
Affiliations
  • Lund University (SE)
  • Eli Lilly (United States) (US)
  • Sahlgrenska University Hospital (SE)
Corresponding author
Hansson, Oskar
Venue
Nature Aging
Published
2020-11-30
Volume
1
Issue
1
Pages
114-123
ISSN
2662-8465 (ISSN-L)
OpenAlex
W3107392275
Cited by
187
References
34
Citations by year
2026: 15 · 2025: 36 · 2024: 39 · 2023: 28 · 2022: 36 · 2021: 33
FWCI
17.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Aging (publishedVersion)
  • medRxiv (acceptedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Knut och Alice Wallenbergs Stiftelse
  • Hjärnfonden
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
mild cognitive impairment, Alzheimer's disease, conversion to dementia, cognitive decline, plasma biomarkers, p-tau181, neurofilament light chain, amyloid-beta, tau protein, neurodegeneration, personalized risk prediction, blood-based biomarkers, web-based prediction tool
MeSH terms
Alzheimer Disease, Humans, Prognosis, Biomarkers, tau Proteins, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations. https://app.cochat.ai/papers/10.1038/s43587-020-00003-5
The paper
Cullen, N. C., Leuzy, A., Palmqvist, S., Janelidze, S., Stomrud, E., Pesini, P., Sarasa, L., Allué, J. A., Proctor, N. K., Zetterberg, H., Dage, J. L., Blennow, K., Mattsson-Carlgren, N., & Hansson, O. (2020). Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations. Nature Aging. https://doi.org/10.1038/s43587-020-00003-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.